This article is more than 5 years old. Information may no longer be current.

Glaukos reports 57% increase in net sales in 2015

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Glaukos reported net sales of $71.7 million in 2015, a 57% increase from $45.6 million reported in 2014, according to a press release.

Net sales in the fourth quarter were reported at $20.3 million, a 44% increase from $14.1 million reported in the same quarter of 2014. The increases in net sales were attributed to higher physician adoption of the iStent trabecular micro-bypass stent.

Net loss attributable to stockholders was reported at $37.2 million, or $2.13 per diluted share, in 2015 compared with $12.1 million, or $5.29 per diluted share, in 2014.

Operating expenses were reported at $69 million in 2015, a 46% increase compared with $47.3 million reported in 2014.

The increase was attributed to higher personnel, travel and other costs associated with expansion of the company’s global infrastructure and sales organization, the release said.